GELS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Gelteq Limited Ordinary Shares

NASDAQ | GELS

1.34

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$13.04M

Market Cap

-

P/E Ratio

-0.35

EPS

$5.50

52 Week High

$0.77

52 Week Low

HEALTHCARE

Sector

GELS Chart

Recent Chart
Price Action

GELS Technicals

Tags:

GELS Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $0
Total Revenue $0
Cost Of Revenue $0
Costof Goods And Services Sold $0
Operating Income -$2.9M
Selling General And Administrative $1.2M
Research And Development $276K
Operating Expenses $2.9M
Investment Income Net -
Net Interest Income -$600K
Interest Income -
Interest Expense $585K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$3.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$3.5M
Comprehensive Income Net Of Tax -
Ebit -$3M
Ebitda -$1.7M
Net Income -$3.5M

Revenue & Profitability

Earnings Performance

GELS Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (AUD)
Total Assets $21M
Total Current Assets $303K
Cash And Cash Equivalents At Carrying Value $25K
Cash And Short Term Investments $25K
Inventory $0
Current Net Receivables $183K
Total Non Current Assets $20M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $20M
Intangible Assets Excluding Goodwill $20M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $96K
Other Non Current Assets -
Total Liabilities $5.6M
Total Current Liabilities $3.9M
Current Accounts Payable $387K
Deferred Revenue -
Current Debt -
Short Term Debt $2.1M
Total Non Current Liabilities $1.8M
Capital Lease Obligations $0
Long Term Debt $1.8M
Current Long Term Debt $2.1M
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.8M
Other Current Liabilities $922K
Other Non Current Liabilities -
Total Shareholder Equity $15M
Treasury Stock -
Retained Earnings -$11M
Common Stock $27M
Common Stock Shares Outstanding $9.4M

yearly Cash Flow (As of Jun 30, 2024)

Field Value (AUD)
Operating Cashflow -$1.1M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -
Capital Expenditures $148K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$148K
Cashflow From Financing $844K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$3.5M

yearly Income Statement (As of Jun 30, 2024)

Field Value (AUD)
Gross Profit $0
Total Revenue $0
Cost Of Revenue $0
Costof Goods And Services Sold $0
Operating Income -$2.9M
Selling General And Administrative $1.2M
Research And Development $276K
Operating Expenses $2.9M
Investment Income Net -
Net Interest Income -$600K
Interest Income -
Interest Expense $585K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$3.5M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$3.5M
Comprehensive Income Net Of Tax -
Ebit -$3M
Ebitda -$1.7M
Net Income -$3.5M

GELS News

GELS Profile

Gelteq Limited Ordinary Shares Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Gelteq Limited (GELS) is an innovative biotechnology firm headquartered in Caulfield, Australia, specializing in the development and commercialization of advanced gel-based delivery systems for both human and veterinary applications. By leveraging cutting-edge technology, Gelteq aims to enhance the efficacy and safety of therapeutic treatments, positioning itself as a key player in the biopharmaceutical landscape. The company's commitment to research and development is underscored by its focus on creating solutions that improve patient outcomes across diverse health sectors.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
IREN
+7.31%
$64.14
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
BULL
+2.98%
$11.74
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
MULN
-55.00%
$0.63
BINI
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BE
+26.54%
$109.93
BTG
+3.87%
$5.27
RGTZ
-50.00%
$9.30
WWR
0.00%
$1.98
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.